Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling

被引:400
作者
Lin, X
Liang, M
Feng, XH
机构
[1] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.C000580200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Smads are important intracellular signaling effecters for transforming growth factor-beta (TGF-beta) and related factors. Proper TGF-beta signaling requires precise control of Smad functions. In this study, we have identified a novel HECT class ubiquitin E3 ligase, designated Smurf2, that negatively regulates Smad2 signaling. In both yeast two-hybrid and in vitro binding assays, we found that Smurf2 could interact with receptor-activated Smads (R-Smads), including Smad1, Smad2, and Smad3 but not Smad4. Ectopic expression of Smurf2 was sufficient to reduce the steady-state levels of Smad1 and Smad2 but not Smad8 or Smad4. Significantly, Smurf2 displayed preference to Smad2 as its target for degradation. Furthermore, Smurf2 exhibited higher binding affinity to activated Smad2 upon TGF-beta stimulation. The ability of Smurf2 to promote Smad2 destruction required the HECT catalytic activity of Smurf2 and depended on the proteasome-dependent pathway. Consistent with these results, Smurf2 potently reduced the transcriptional activity of Smad2. These data suggest that a ubiquitin/proaeasome-dependent mechanism is important for proper regulation of TGF-beta signaling.
引用
收藏
页码:36818 / 36822
页数:5
相关论文
共 37 条
  • [1] c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads
    Akiyoshi, S
    Inoue, H
    Hanai, J
    Kusanagi, K
    Nemoto, N
    Miyazono, K
    Kawabata, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) : 35269 - 35277
  • [2] Smad4 and FAST-1 in the assembly of activin-responsive factor
    Chen, X
    Weisberg, E
    Fridmacher, V
    Watanabe, M
    Naco, G
    Whitman, M
    [J]. NATURE, 1997, 389 (6646) : 85 - 89
  • [3] Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO
  • [4] 2-Q
  • [5] The Smads: transcriptional regulation and mouse models
    Datto, M
    Wang, XF
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (1-2) : 37 - 48
  • [6] Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases
    de Caestecker, MP
    Parks, WT
    Frank, CJ
    Castagnino, P
    Bottaro, DP
    Roberts, AB
    Lechleider, RJ
    [J]. GENES & DEVELOPMENT, 1998, 12 (11) : 1587 - 1592
  • [7] Smads:: Transcriptional activators of TGF-β responses
    Derynck, R
    Zhang, Y
    Feng, XH
    [J]. CELL, 1998, 95 (06) : 737 - 740
  • [8] Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β
    Feng, XH
    Lin, X
    Derynck, R
    [J]. EMBO JOURNAL, 2000, 19 (19) : 5178 - 5193
  • [9] The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation
    Feng, XH
    Zhang, Y
    Wu, RY
    Derynck, R
    [J]. GENES & DEVELOPMENT, 1998, 12 (14) : 2153 - 2163
  • [10] A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity
    Feng, XH
    Derynck, R
    [J]. EMBO JOURNAL, 1997, 16 (13) : 3912 - 3923